Stock Screener App

Frei -

46.88

0.71% 0.33

Belite Bio Inc Adr (BLTE)

Überblick Nachrichten Preisverlauf Forum Prognose

Belite Bio Inc Adr Aktie (BLTE) Neueste Nachrichten

Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing - GlobeNewswire

Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing - Yahoo Finance

Armistice Capital LLC Invests $6.76 Million in Belite Bio, Inc (NASDAQ:BLTE) - MarketBeat

International companies to host live webcasts at Deutsche - GlobeNewswire

Belite Bio, Inc (NASDAQ:BLTE) Short Interest Down 5.1% in August - MarketBeat

International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on September 24th and 25th, 2024 - GlobeNewswire Inc.

Belite Bio (NASDAQ:BLTE) Rating Reiterated by HC Wainwright - Defense World

Belite Bio shares hold buy rating, steady target on trial progress - Investing.com

Belite Bio's (BLTE) Buy Rating Reiterated at HC Wainwright - MarketBeat

Belite Bio shares hold buy rating, steady target on trial progress - Investing.com India

Belite Bio Announces First Patient Dosed in Phase 2/3 - GlobeNewswire

Belite Bio Announces First Patient Dosed in Phase 2/3 DRAGON II Trial of Tinlarebant for the Treatment of Stargardt Disease - StockTitan

Belite Bio 宣佈委任醫學博士Hendrik P. N. Scholl 為首席醫療總監 - GlobeNewswire Inc.

ベライト・バイオ (Belite Bio)、ヘンドリック・P・N・ショル医学博士、修士 (Hendrik P. N. Scholl, MD, MA) をチーフ・メディカル・オフィサーに任命 - GlobeNewswire Inc.

Belite Bio Welcomes New Chief Medical Officer - TipRanks

Belite Bio to Participate in Three Upcoming Investor Conferences - StockTitan

Belite Bio, Inc (NASDAQ:BLTE) Short Interest Down 9.6% in August - MarketBeat

Belite Bio Announces Appointment of Hendrik P. N. Scholl, MD, MA, as Chief Medical Officer - ForexTV.com

Belite Bio Announces Appointment of Hendrik P. N. Scholl, MD, MA, as Chief Medical Officer - GlobeNewswire Inc.

Belite Bio (NASDAQ:BLTE) Sees Strong Trading Volume - Defense World

Belite Bio (NASDAQ:BLTE) Sees Large Volume Increase - MarketBeat

Short Interest in Belite Bio, Inc (NASDAQ:BLTE) Expands By 10.7% - MarketBeat

Belite Bio (NASDAQ:BLTE) Trading Down 1.8% - MarketBeat

HC Wainwright Analysts Decrease Earnings Estimates for Belite Bio, Inc (NASDAQ:BLTE) - Defense World

FY2024 EPS Estimates for Belite Bio, Inc Lowered by Analyst (NASDAQ:BLTE) - Defense World

Golden Ocean Group (NASDAQ:GOGL) Downgraded to Sell at StockNews.com - Defense World

Abtech (OTCMKTS:ABHD) Shares Cross Above 50 Day Moving Average of $1.08 - Defense World

Cambian Group (LON:CMBN) Stock Price Crosses Below Two Hundred Day Moving Average of $192.40 - Defense World

Leerink Partnrs Equities Analysts Cut Earnings Estimates for Belite Bio, Inc (NASDAQ:BLTE) - Defense World

Leerink Partnrs Equities Analysts Cut Earnings Estimates for Belite Bio, Inc (NASDAQ:BLTE) - MarketBeat

Price T Rowe Associates Inc. MD Purchases 357 Shares of National Bankshares, Inc. (NASDAQ:NKSH) - Defense World

Q3 2024 EPS Estimates for Esperion Therapeutics, Inc. (NASDAQ:ESPR) Reduced by HC Wainwright - Defense World

Barnes & Noble Education (NYSE:BNED) Shares Pass Above 50 Day Moving Average of $7.94 - Defense World

QRG Capital Management Inc. Has $244,000 Holdings in Qifu Technology, Inc. (NASDAQ:QFIN) - Defense World

California State Teachers Retirement System Cuts Position in F&G Annuities & Life, Inc. (NYSE:FG) - Defense World

California State Teachers Retirement System Cuts Stake in Cassava Sciences, Inc. (NASDAQ:SAVA) - Defense World

Contrasting Priority Technology (NASDAQ:PRTH) and Swvl (NASDAQ:SWVL) - Defense World

Belite Bio, Inc to Post Q1 2025 Earnings of ($0.29) Per Share, HC Wainwright Forecasts (NASDAQ:BLTE) - MarketBeat

AstroNova, Inc. (NASDAQ:ALOT) Short Interest Down 44.4% in July - Defense World

Belite Bio (NASDAQ:BLTE) Receives “Buy” Rating from Benchmark - Defense World

Chardan Capital Research Analysts Raise Earnings Estimates for Ocugen, Inc. (NASDAQ:OCGN) - Defense World

Q3 2024 EPS Estimates for Sun Life Financial Inc. Increased by National Bank Financial (TSE:SLF) - Defense World

QRG Capital Management Inc. Sells 8,711 Shares of Vipshop Holdings Limited (NYSE:VIPS) - Defense World

Roth Capital Research Analysts Decrease Earnings Estimates for Revelation Biosciences, Inc. (NASDAQ:REVB) - Defense World

Q3 2024 Earnings Estimate for Soho House & Co Inc. Issued By Roth Capital (NYSE:SHCO) - Defense World

Raymond James Lowers Parkit Enterprise (CVE:PKT) to Hold - Defense World

155675 (BLD.TO) (TSE:BLD) Lowered to “Strong Sell” at Cibc World Mkts - Defense World

European Commercial REIT (TSE:ERE) Upgraded to “Moderate Buy” by Desjardins - Defense World

155675 (BLD.TO) (TSE:BLD) Downgraded by TD Securities - Defense World

HC Wainwright Comments on Summit Therapeutics Inc.’s Q3 2024 Earnings (NASDAQ:SMMT) - Defense World

PowerHouse Energy Group (LON:PHE) Trading Up 6.9% - Defense World

Q3 2024 EPS Estimates for FiscalNote Holdings, Inc. Boosted by Northland Capmk (NYSE:NOTE) - Defense World

Sun Life Financial Inc. (SLF) To Go Ex-Dividend on August 28th - Defense World

Belite Bio (NASDAQ:BLTE) Given New $60.00 Price Target at HC Wainwright - Defense World

Woori Financial Group Inc. (NYSE:WF) Position Boosted by Sequoia Financial Advisors LLC - Defense World

Campbell Soup (NYSE:CPB) Upgraded to Hold at StockNews.com - Defense World

Avalon Advanced Materials Inc. (OTCMKTS:AVLNF) Short Interest Update - Defense World

Stifel Canada Downgrades Centric Health (TSE:CRX) to Hold - Defense World

Interactive Brokers Group, Inc. (NASDAQ:IBKR) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World

Belite Bio (NASDAQ:BLTE) Given New $60.00 Price Target at HC Wainwright - MarketBeat

Belite Bio shares target raised, rating reiterated on Japan drug prospects - Investing.com Canada

Belite Bio shares target raised, rating reiterated on Japan drug prospects - Investing.com

Earnings call: Belite Bio reports progress in Tinlarebant trials, Q2 financials - Investing.com Australia

Belite Bio's (BLTE) Buy Rating Reaffirmed at Benchmark - MarketBeat

Belite Bio shares target raised, rating reiterated on Japan drug prospects - Investing.com UK

Earnings call: Belite Bio reports progress in Tinlarebant trials, Q2 financials - Investing.com Canada

Earnings call: Belite Bio reports progress in Tinlarebant trials, Q2 financials - Investing.com

Earnings call: Belite Bio reports progress in Tinlarebant trials, Q2 financials - Investing.com UK

Belite Bio (NASDAQ:BLTE) Shares Gap Down After Earnings Miss - Defense World

Belite Bio, Inc (BLTE) Q2 2024 Earnings Call Transcript - Seeking Alpha

Belite Bio (NASDAQ:BLTE) Shares Gap Down Following Weak Earnings - MarketBeat

Belite Bio (NASDAQ:BLTE) Announces Quarterly Earnings Results - Defense World

$358.35

0.05%

$21.90

4.86%

$224.51

2.79%

$66.83

1.64%

$118.77

0.47%

$542.08

1.11%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | Open in MarketWatch | Open in EDGAR | Open in Reuters